Pending the European Commission final decision, regimen offers a new standard of care for eligible MCL patients1,2Positive opinion reinforces Phase...
If approved, daratumumab will be the first authorised treatment option for patients with smouldering multiple myeloma at high-risk of developing...
Positive recommendation based on resmetirom’s favorable profile including positive results from the pivotal Phase 3 MAESTRO-NASH trialEuropean Commission decision expected...
If approved, Cabometyx® would be the first and only systemic therapy approved in the European Union for previously treated neuroendocrine...
TORONTO and HAIFA, Israel, June 20, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone”...
Approval based on pivotal results showing improvements in sustained disease remission and reductions in itch and oral corticosteroid use compared...
Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid Approval based on pivotal...
MELBOURNE, Australia and INDIANAPOLIS, June 20, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”)...
PRESS RELEASE Memo Therapeutics AG to Present Interim Phase II Results of Potravitug for the Treatment of BKV Infection in...
Alpha-emitting radioisotope expected to play an essential role in next-generation targeted cancer therapiesDURHAM, N.C. and WEST VALLEY CITY, Utah, June...
On the sidelines of a high-level US visit focused on healthcare innovation ABU DHABI, UAE, June 18, 2025 /PRNewswire/ --...
BOSTON, June 18, 2025 /PRNewswire/ -- Lindus Health, the anti-CRO running radically faster, more reliable clinical trials, has been honored...
DURHAM, N.C., June 18, 2025 /PRNewswire/ -- Pluto Health, a leader in digitally enabled care coordination, is proud to announce...
ROCHESTER, Minn., June 18, 2025 /PRNewswire/ -- With the rising popularity of dietary supplements and functional health products, consumers face an...
Sanofi, Recursion, and Velocity Clinical Research Executives Join Council as Founding Members to Guide Responsible AI Use in Clinical Research...
The new platform is designed to break down barriers to early-phase trial access, bringing "Hope Through Access" to communities and...
RMPY-008 is the first app-based intervention to demonstrate rapid modulation of inflammatory blood biomarkers, acting like a digital antibody in...
Investors, Entrepreneurs, and Industry Experts to Convene at the Premier Psychedelic Science Business Forum hosted by Multidisciplinary Association for Psychedelic...
Differentiated PH1 payload is a spliceosome inhibitor designed to inhibit RNA splicing, leading to cancer cell death and activation of...
- Prenetics adopts proven corporate Bitcoin strategy inspired by MicroStrategy's ~$40B Bitcoin holdings and Metaplanet's meteoric treasury transformation - Following...